$72.27
0.45% yesterday
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US4364401012
Symbol
HOLX

Hologic Target price 2024 - Analyst rating & recommendation

Hologic Classifications & Recommendation:

Buy
38%
Hold
58%
Sell
4%

Hologic Price Target

Target Price $87.63
Price $72.27
Potential
Number of Estimates 16
16 Analysts have issued a price target Hologic 2025 . The average Hologic target price is $87.63. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 24 analysts: 9 Analysts recommend Hologic to buy, 14 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hologic stock has an average upside potential 2025 of . Most analysts recommend the Hologic stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Billion $ 4.03 4.18
0.00% 3.60%
EBITDA Margin 31.74% 33.18%
1.17% 4.54%
Net Margin 19.09% 19.55%
81.43% 2.42%

19 Analysts have issued a sales forecast Hologic 2025 . The average Hologic sales estimate is

$4.2b
Unlock
. This is
3.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.3b 7.53%
Unlock
, the lowest is
$4.1b 1.12%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $4.0b 0.00%
2025
$4.2b 3.60%
Unlock
2026
$4.4b 5.84%
Unlock
2027
$4.7b 6.21%
Unlock
2028
$5.0b 6.33%
Unlock
2029
$5.2b 3.25%
Unlock

17 Analysts have issued an Hologic EBITDA forecast 2025. The average Hologic EBITDA estimate is

$1.4b
Unlock
. This is
8.32% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.5b 15.12%
Unlock
, the lowest is
$1.3b 4.28%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $1.3b 1.17%
2025
$1.4b 8.31%
Unlock
2026
$1.5b 7.38%
Unlock
2027
$1.6b 5.88%
Unlock
2028
$1.7b 6.98%
Unlock
2029
$1.8b 7.11%
Unlock

EBITDA Margin

2024 31.74% 1.17%
2025
33.18% 4.54%
Unlock
2026
33.67% 1.48%
Unlock
2027
33.56% 0.33%
Unlock
2028
33.76% 0.60%
Unlock
2029
35.03% 3.76%
Unlock

8 Hologic Analysts have issued a net profit forecast 2025. The average Hologic net profit estimate is

$816m
Unlock
. This is
6.12% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$849m 10.36%
Unlock
, the lowest is
$742m 3.61%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $769m 81.42%
2025
$816m 6.12%
Unlock
2026
$911m 11.56%
Unlock
2027
$1.0b 13.24%
Unlock
2028
$1.2b 16.16%
Unlock

Net Margin

2024 19.09% 81.43%
2025
19.55% 2.42%
Unlock
2026
20.61% 5.42%
Unlock
2027
21.97% 6.60%
Unlock
2028
24.00% 9.24%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share $ 3.32 3.52
81.42% 6.02%
P/E 20.61
EV/Sales 4.02

8 Analysts have issued a Hologic forecast for earnings per share. The average Hologic <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$3.52
Unlock
. This is
6.02% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$3.66 10.24%
Unlock
, the lowest is
$3.20 3.61%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $3.32 81.42%
2025
$3.52 6.02%
Unlock
2026
$3.93 11.65%
Unlock
2027
$4.45 13.23%
Unlock
2028
$5.17 16.18%
Unlock

P/E ratio

Current 21.86 43.72%
2025
20.61 5.72%
Unlock
2026
18.47 10.38%
Unlock
2027
16.31 11.69%
Unlock
2028
14.04 13.92%
Unlock

Based on analysts' sales estimates for 2025, the Hologic stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.17 2.57%
2025
4.02 3.51%
Unlock
2026
3.80 5.52%
Unlock
2027
3.58 5.85%
Unlock
2028
3.37 5.96%
Unlock
2029
3.26 3.14%
Unlock

P/S ratio

Current 4.09 3.36%
2025
3.95 3.48%
Unlock
2026
3.73 5.52%
Unlock
2027
3.51 5.85%
Unlock
2028
3.30 5.96%
Unlock
2029
3.20 3.14%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today